THE INFLUENCE OF CHOLESTYRAMINE ON THE ELIMINATION OF TENOXICAM AND PIROXICAM

被引：33

作者：

GUENTERT, TW ^{[1
]}

DEFOIN, R ^{[1
]}

MOSBERG, H ^{[1
]}

机构：

[1] LAB CO LTD,NEU ULM,FED REP GER

来源：

关键词：

D O I：

10.1007/BF00540957

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：283 / 289

页数：7

共 19 条

[1] ENHANCEMENT OF THEOPHYLLINE CLEARANCE BY ORAL ACTIVATED-CHARCOAL
BERLINGER, WG
SPECTOR, R
GOLDBERG, MJ
JOHNSON, GF
QUEE, CK
BERG, MJ
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (03) : 351 - 354
[2] BOYLAN JJ, 1979, CLIN PHARMACOL THER, V25, P579
[3] INTESTINAL SECRETION OF DIGOXIN IN THE RAT - AUGMENTATION BY FEEDING ACTIVATED-CHARCOAL
CALDWELL, JH
CALDWELL, PB
MURPHY, JW
BEACHLER, CW
[J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1980, 312 (03) : 271 - 275
[4] CREVOISIER C, 1986, EULAR LIT RHEUM, V5, P7
[5] QUANTITATION OF BILIARY-EXCRETION OF DRUGS IN MAN
DUJOVNE, CA
GUSTAFSON, JH
DICKEY, RA
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (02) : 187 - 194
[6] FACTORS AFFECTING THE KINETICS OF 2 BENZOTHIAZINE NON-STEROIDAL ANTI-INFLAMMATORY MEDICINES, PIROXICAM AND ISOXICAM
EDWARDS, IR
FERRY, DG
CAMPBELL, AJ
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 28 (06) : 689 - 692
[7] FOURTILLAN JB, 1983, RHUMATOLOGIE, V35, P11
[8] GIBALDI M, 1982, PHARMACOKINETICS
[9] GUENTERT TW, 1986, J PHARMACOL EXP THER, V238, P295
[10] Heintz R C, 1984, Eur J Rheumatol Inflamm, V7, P33